mTOR inhibitor OSI-027, Purity ≥98%

Cat. No.: X24-05-ZQ036

mTOR inhibitor OSI-027, Purity ≥98%

Synonym: 936890-98-1; OSI027; mTOR inhibitor

  • CAS Number: 936890-98-1
  • Compound CID: 135398516
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
OSI-027, soluble in DMSO and insoluble in ethanol and water, disrupts cell growth, proliferation, and survival by targeting a key component of cellular signaling pathways. It targets mTORC1, mTORC2, ACK1, BTK, C-Raf, DNA-PK, EGFR/ErbB1, EphA2, Fyn, IGF-1R, and insulin receptor.
Molecular Weight
406.4
Molecular Formula
C21H22N6O3
Targets
mTORC1: 22 nM; mTORC2: 65 nM; ACK1: >10 μM; BTK: 5.0 μM; C-Raf: 1.6 μM; DNA-PK: 1.0 μM; EGFR/ErbB1: >30 μM; EphA2: 4.5 μM; Fyn: >30 μM; IGF-1R: >30 μM; InsulinReceptor: >30 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 16 mg/mL (39.36 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
OSI-027 can be employed to investigate dual mTORC1 and mTORC2 inhibition in oncology research.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.